Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

        Center for Veterinary Medicine

CVM FOIA Electronic Reading Room Home
          About FDA
          FDA Organization
          Center for Veterinary Medicine
          CVM FOIA Electronic Reading RoomCenter for Veterinary Medicine CVM FOIA Electronic Reading Room
  	
        Share
    Post
    Linkedin

    Email
    PrintHow to Make a FOIA RequestFDA Electronic Reading Room

Policy Statements

Guidance for IndustryAdministrative Staff Manuals

CVM's Policy & Procedures Manual
	Manual of Compliance Policy GuidesProduct Approval Information

Freedom of Information (FOI) Summaries for Approved and Conditionally Approved Animal Drugs
	Veterinary Master Files
	Environmental Impact Considerations
	NSAID Labels
	Method of Analysis N-methyl-2-pyrrolidone (PDF - 188KB)Analytical Methods

*Persons using assistive technology may not be able to fully access information in these methods. For assistance, please email AskCVM@fda.hhs.gov or call 240-402-7002.*

Quantitative Procedure for Residues of Albendazole in Cattle Liver
	Determination of Amprolium in Eggs and Meat and Meat Products of Chickens
	Determination of Apramycin in Swine Tissue
	Determination of Carbadox (as Quinoxaline-2-Carboxylic [QCA]) Residues in Swine Liver and Muscle Tissues After Drug Withdrawal
	Determinative and Confirmatory Procedures for the Assay of Fenbendazole Sulfone in Chicken Egg using LC-MS/MS
	Determinative and Confirmatory Procedures for Fenbendazole Sulfone in Liver Tissues of Broiler Chicken Using LC-MS/MS, Version 6.0
	Determinative and Confirmatory Procedures for the Detection of Fenbendazole in Liver Tissues of Swine Using LC-MS/MS v. 6.0
	Determinative and Confirmatory Procedures for the Analysis of Fenbendazole Sulfone in Turkey Liver Tissue Using LC-MS/MS, Version 9.0
	Determination and Confirmation of Lubabegron in Bovine Liver Tissue by LC-MS/MS
	Determination and Confirmation Analysis of Lufenuron Residues in Salmon and Trout Tissue by Liquid Chromatography-Tandem Mass Spectrometry Atmospheric Pressure Chemical Ionization (LC-MS/MS APCI)
	Determinative and Confirmatory Procedures for the Analysis of Oxfendazole in Cattle Milk Using LC-MS/MS, Version 6Compliance & Enforcement



Warning Letters
	Advisory Action Letters
	Medicated Feeds
	Ruminant Feed Inspections
	CVM Letter to Feed and Feed Ingredient Manufacturers
	Establishment Inspection Report - Gambol Pet Products Co. (PDF - 7.2MB)
	Establishment Inspection Report - Jinan Uniwell Pet Food Co., Ltd. (PDF - 5.8MB)
	Establishment Inspection Report - Shandong Honva Food Co. Ltd. (PDF - 7.4MB)
	Establishment Inspection Report - Shandong Petswell Food Co. Ltd. (PDF - 5.7MB)
	2010 Jerky Complaints (PDF - 242KB)
	2011 Jerky Complaints (PDF - 4.9MB)
	2012-January 2013 Jerky Complaints (PDF - 25.3MB)
	February 2013-September 2013 Jerky Complaints (PDF - 1MB)
	September 2013-May 2014 Jerky Complaints (PDF - 1.9MB)
	May-September 2014 Jerky Complaints (PDF - 502KB)
	Establishment Inspection Report - Yantai Aska Food (PDF - 4.5MB)
	Yantai Aska Foods 483 (PDF - 238KB)
	Establishment Inspection Report - Acidchem (PDF - 5.8MB)
	Letter to Kasel Associates Industries, Inc. - Notification of Opportunity to Initiate a Voluntary Recall (PDF - 6.4MB)Eric Nelson Calendar Records – FOIA 2020-6396
	FDA-CVM-FOIA-2020-6396-CVM002 – FDA-CVM-FOIA-2020-6396-CVM031
	FDA-CVM-FOIA-2020-6396-CVM063 – FDA-CVM-FOIA-2020-6396-CVM091

Safety & Health

Adverse Event Reports for Animal Drugs and Devices
	Veterinary Medicine Advisory Committee
	Target Animal Safety Review Memorandum: Trace Metal Analysis of Commercial Pet Food for Toxic Metals (PDF - 470KB)
	Food and Drug Administration/Center for Veterinary Medicine Report on the Risk from Pentobarbital in Dog Food
	CVM's researchers have concluded that the low levels of exposure to pentobarbital that dogs might receive through pet food is unlikely to cause them any adverse health effects.
	FDA Records Related to Nestle Purina Beneful Dry Dog Food
	Response for Request for Adverse Event Reports Received for Afoxolaner, Fluralaner, Lotilaner, and Sarolaner
	FDA CVM Comprehensive ADE Report Listing for Afoxolaner (Nexgard): 9/4/13 - 7/31/18
		FDA CVM Comprehensive ADE Report Listing for Fluralaner (Bravecto): 9/4/13 - 7/31/18
		FDA CVM Comprehensive ADE Report Listing for Lotilaner (Credelio): 9/4/13 - 7/31/18
		FDA CVM Comprehensive ADE Report Listing for Sarolaner (Simparica): 9/4/13 - 7/31/18
	Dr. Steven Solomon Presentation -- NGFA‐PFI FEED AND PET FOOD JOINT CONFERENCE -- September 2018
	AFIA Salmonella Webcast PowerPoint – April 2010Canine Dilated Cardiomyopathy

Canine Dilated Cardiomyopathy Complaints Submitted to FDA-CVM Through April 30, 2019Canine Dilated Cardiomyopathy - FOIA 2019-1704
	FDA CVM FOIA-2019-1704-001147 - FDA CVM FOIA-2019-1704-001161
	FDA CVM FOIA 2019-1704-001191 - FDA CVM FOIA 2019-1704-003926
	FDA CVM FOIA 2019-1704-001255 - FDA CVM FOIA 2019-1704-007577
	FDA-CVM-FOIA-2019-1704-001174 - FDA-CVM-FOIA-2019-1704-006003
	FDA-CVM-FOIA-2019-1704-006219 - FDA-CVM-FOIA-2019-1704-007609
	FDA-CVM-FOIA-2019-1704-001150 - FDA-CVM-FOIA-2019-1704-003878
	FDA-CVM-FOIA-2019-1704-003881 - FDA-CVM-FOIA-2019-1704-007572
	FDA-CVM-FOIA-2019-1704-001220 - FDA-CVM-FOIA-2019-1704-003375
	FDA-CVM-FOIA-2019-1704-003383 - FDA-CVM-FOIA-2019-1704-005966
	FDA-CVM-FOIA-2019-1704-005970 - FDA-CVM-FOIA-2019-1704-007592
	FDA-CVM-FOIA-2019-1704-001611 - FDA-CVM-FOIA-2019-1704-008063
	FDA-CVM-FOIA-2019-1704-008064 - FDA-CVM-FOIA-2019-1704-015075
	FDA-CVM-FOIA-2019-1704-001611 - FDA-CVM-FOIA-2019-1704-009511
	FDA-CVM-FOIA-2019-1704-009522 - FDA-CVM-FOIA-2019-1704-011552
	FDA-CVM-FOIA-2019-1704-011559 - FDA-CVM-FOIA-2019-1704-013713
	FDA-CVM-FOIA-2019-1704-013716 - FDA-CVM-FOIA-2019-1704-014895
	FDA-CVM-FOIA-2019-1704-014896 - FDA-CVM-FOIA-2019-1704-015185
	FDA-CVM-FOIA-2019-1704-001355 - FDA-CVM-FOIA-2019-1704-010458
	FDA-CVM-FOIA-2019-1704-011203 - FDA-CVM-FOIA-2019-1704-012278
	FDA-CVM-FOIA-2019-1704-012279 - FDA-CVM-FOIA-2019-1704-014284
	FDA-CVM-FOIA-2019-1704-014285 - FDA-CVM-FOIA-2019-1704-015385
	FDA-CVM-FOIA-2019-1704-002503 - FDA-CVM-FOIA-2019-1704-002744
	FDA CVM FOIA-2019-1704-000001 - FDA CVM FOIA-2019-1704-000117
	FDA CVM FOIA-2019-1704-000118 - FDA CVM FOIA-2019-1704-000522
	FDA CVM FOIA-2019-1704-000523 - FDA CVM FOIA-2019-1704-000700
	FDA CVM FOIA-2019-1704-000701 - FDA CVM FOIA-2019-1704-001146
	FDA CVM FOIA-2019-1704-001162 - FDA CVM FOIA-2019-1704-005892
	FDA CVM FOIA-2019-1704-005921 - FDA CVM FOIA-2019-1704-010294
	FDA CVM FOIA-2019-1704-010297 - FDA CVM FOIA-2019-1704-011237
	FDA CVM FOIA-2019-1704-011507 - FDA CVM FOIA-2019-1704-013797
	FDA CVM FOIA-2019-1704-013878 - FDA CVM FOIA-2019-1704-015207
	FDA CVM FOIA-2019-1704-015208 - FDA CVM FOIA-2019-1704-015676
	FDA CVM FOIA-2019-1704-015677 - FDA CVM FOIA-2019-1704-016176
	FDA CVM FOIA-2019-1704-016177 - FDA CVM FOIA-2019-1704-016517
	FDA CVM FOIA-2019-1704-016518 - FDA CVM FOIA-2019-1704-016808
	FDA CVM FOIA-2019-1704-016809 - FDA CVM FOIA-2019-1704-017325
	FDA CVM FOIA-2019-1704-017326 - FDA CVM FOIA-2019-1704-017770
	FDA CVM FOIA-2019-1704-017771 - FDA CVM FOIA-2019-1704-018116
	FDA CVM FOIA-2019-1704-018117 - FDA CVM FOIA-2019-1704-018662
	FDA CVM FOIA-2019-1704-018663 - FDA CVM FOIA-2019-1704-019385

High Pressure Processing (HPP) – FOIA 2018-7843

FDA-CVM-FOIA-Case-1-20-cv-00656-000002780 - FDA-CVM-FOIA-Case-1-20-cv-00656-000002784
	FDA-CVM-FOIA-Case-1-20-cv-00656-000004099
	FDA-CVM-FOIA-Case-1-20-cv-00656-000004100 - FDA-CVM-FOIA-Case-1-20-cv-00656-000004118Adverse Event Reports

Adverse Event Reports - May 1, 2010-May 1, 2011
	Adverse Event Reports - May 2, 2011-May 1, 2012
	Adverse Event Reports - May 2, 2012-May 1, 2013
	Adverse Event Reports - May 2, 2013-May 1, 2014 - Part 1
	Adverse Event Reports - May 2, 2013-May 1, 2014 - Part 2
	Adverse Event Reports - May 2, 2013-May 1, 2014 - Part 3
	Adverse Event Reports - May 2, 2014-May 1, 2015
	Adverse Event Reports - May 2, 2015-May 1, 2016
	Adverse Event Reports - May 2, 2016-May 1, 2017
	Adverse Event Reports - May 2, 2017-May 1, 2018
	Adverse Event Reports - May 2, 2018-May 1, 2019
	Adverse Event Reports - May 2, 2019-May 1, 2020
	Adverse Event Reports - May 2, 2020-May 1, 2021
	Adverse Event Reports - May 2, 2021-June 10, 2022

                                                                                  Content current as of:
      09/29/2023CVM FOIA Electronic Reading Room
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop